Serum Free Fatty Acids and Glucose Metabolism, Insulin Resistance in Schizophrenia with Chronic Antipsychotics

Biological Psychiatry

Volumn 60, Issue 12, 2006, Pages 1309-1313

  Wang, Cong jie ^a   Zhang, Zhi jun ^c   Sun, Jing ^b   Zhang, Xiao bing ^d   Mou, Xiao dong ^c   Zhang, Xiang rong ^b   Shang, Xiao fang ^b   Zhang, Tai quan ^e  

^a Department of Psychiatry   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c SOUTHEAST UNIVERSITY   (China)

^d Yangzhou Wutaishan Hospital   (China)

^e Department of Psychiatry   (China)

Author keywords

Fasting blood glucose; insulin resistance; schizophrenia; serum free fatty acids

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; FATTY ACID; GLIBENCLAMIDE; GLICLAZIDE; GLIPIZIDE; GLUCOSE; HALOPERIDOL; INSULIN; LEPTIN; NEUROLEPTIC AGENT; PERPHENAZINE; SULPIRIDE;

ADULT; ARTICLE; BODY MASS; COLORIMETRY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SCHIZOPHRENIA; SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; BLOOD GLUCOSE; BODY MASS INDEX; COLORIMETRY; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; OBESITY; PSYCHIATRIC STATUS RATING SCALES; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; SCHIZOPHRENIA;

EID: 33751512689     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.03.014     Document Type: Article

References (24)

1. Anuurad E., Shiwaka K., Nogi A., Kitajima K., Enkhmaa B., Shimono K., et al. The new BMI criteria for Asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J Occup Health 45 (2003) 335-343
2. Buse J.B. Metabolic side effects of antipsychotics: focus on hyperglycemia and diabetes. J Clin Psychiatry 63 Suppl 4 (2002) 37-41
3. Carpentier A., Mittelman S.D., Lamarche B., Bergman R.N., Giacca A., Lewis G.F., et al. Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol 276 (1999) E1055-E1066
4. Chu C.A., Sherck S.M., and Igawa K. Effects of free fatty acids on heptic glycogenolysis and gluconeo-genesis in conscious dogs. Am J Psyiol Endocrinal Metab 282 2 (2002) E402-E411
5. Dhindsa S., Tripathy D., Sanalkumar N., Ravishankar S., Ghanim H., Aljada A., et al. Free fatty acid induced insulin resistance in the obese is not prevented by rosiglitazone treatment. J Clin Endocrinol Metab 90 9 (2005) 5058-5063
6. Dresner A., Laurent D., Marcucci M., Griffin M.E., Dufour S., Cline G.W., et al. Effects of free fatty acids on glucose transport and IRS-1- associated phosphatidylinositol 3-kinase activity. J Clin Invest 103 (1999) 253-259
7. Hägg S., Joelsson L., MjÖrndal T., Spigset O., Oja G., and Dahlqvist R. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications. J Clin Psychiatry 59 (1998) 294-299
8. Hawkins M., Tonelli J., and Kishore P. Contribution of elevated free acid levels to the lack of glucose effectives in type 2 diabetes. Diabetes 52 (2003) 2748-2758
9. Heiskanen T., Niskanen L., Lyytikäinen R., Saarinen P.I., and Hintikka J. Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry 64 5 (2003) 575-579
10. Henderson D.C., Cagliero E., Copeland P.M., Borba C.P., Evins E., Hayden D., et al. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents. Arch Gen Psychiatry 62 (2005) 19-28
11. Henderson D.C. Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?. CNS Drugs 16 (2002) 77-89
12. Hennes M.M., Dua A., and Kissebah A.H. Effects of free fatty acids and glucose on splanchnic insulin dynamics. Diabetes 46 (1997) 57-62
13. Hermans M.P., Levy J.C., Morris R.J., and Turner R.C. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 42 (1999) 678-687
14. Lebovitz H.E. Diagnosis, classification, and pathogenesis of diabetes mellitus. J Clin Psychiatry 62 suppl 27 (2001) 5-9
15. Lieberman J.A., Tollefson G., Tohen M., Green A.I., Gur R.E., Kahn R., et al. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blinded trial of olanzapine versus haloperidol. Am J Psychiatry 160 8 (2003) 1401-1403
16. Lupi R., Dotta F., Marselli L., Guerra S.D., Masini M., Santangelo C., et al. Prolonged Exposure to Free Fatty Acids has Cytostatic and Pro-Apoptotic Effects on Human Pancreatic Islets. Diabetes 51 (2002) 1437-1442
17. Matsuoka N., Ogawa Y., Hosoda K., Matsuda J., Masuzaki H., and Miyawaki T. Human leptin receptor gene in obese japanese subjects: evidence against either obesity-causing mutations or association of sequence variants with obesity. Diabetologia 40 (1997) 1204-1210
18. Mukherjee S., Decina P., Bocola V., Saraceni F., and Scapicchio P.L. Diabetes mellitus in schizophrenic patients. Compr Psychiatry 37 (1996) 68-73
19. Newcomer J.W. Metabolic disturbances associated with antipsychotic use. J Clin Psychiatry 62 suppl 27 (2001) 3
20. Perez-Martin A., Raynaud E., Hentgen C., Bringer J., Mercier J., Brun J.F., et al. Simplified measurement of insulin sensitivity with the mininmal model procedure in type 2 diabetic patients without measurement of insulinemia. Horm Metab Res 34 (2002) 102-106
21. Seufert J. Leptin effects on pancreatic β-cell gene expression and function. Diabetes 53 suppl. 1 (2004) S152-S158
22. Shulman G.I. Cellular mechanisms of insulin resistance. J Clin Invest 106 (2000) 171-176
23. Stromblad G., and Bjorntorp P. Reduced hepatic insulin clearance in rats with dietary-induced obesity. Metabolism 35 (1986) 323-327
24. 4 translocation in skeletal muscle of high fat-fed rats is associated with alternation in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities. Diabetes 50 8 (2001) 1901-1910